Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$7.06
-9.02%
Mkt Cap $605.14M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$22.00
Range $18.00 – $28.00
Implied Upside
+211.8%
Consensus $22.00 vs current $7.06
NASDAQ·Healthcare·Biotechnology
$7.06
-9.02%
Mkt Cap $605.14M
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$22.00
Range $18.00 – $28.00
+211.8%
Consensus $22.00 vs current $7.06